Teva and OncoGenex announce top-line survival results of Phase III SYNERGY trial evaluating custirsen in combination with first-line docetaxel and prednisone - Drug Target Review
Why You Should Still Buy Teva (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals: Making Quality Health Care Accessible
Teva Pharmaceuticals - Wikipedia
Teva, MedinCell announce positive results for registration trial of TV-46000/mdc-IRM for patients with Schizophrenia - Pharmaceutical Business review